1. What is an anticancer drug?
Anticancer drugs refer to drugs that can inhibit the growth and spread of cancer cells. According to their different mechanisms of action, anticancer drugs can be divided into chemotherapy drugs, targeted drugs, immunotherapy drugs and other types. These drugs have their unique modes of action and indications.
Second, the best anti-cancer drugs in China
1. rapatinib
Rapatinib is a targeted drug, which is mainly used to treat hepatocellular carcinoma and colorectal cancer. The therapeutic effect is achieved by inhibiting the growth and diffusion of tumor cells. Rapatinib has become one of the most important drugs in the treatment of hepatocellular carcinoma and colorectal cancer because of its remarkable curative effect and few adverse reactions.
2. Oxitinib
Oxitinib is a targeted drug, which is mainly used to treat lung cancer and gastric cancer. It inhibits the growth and spread of tumor cells by targeting tyrosine kinase on tumor cells. Because of its remarkable curative effect and few adverse reactions, oxitinib has become one of the important drugs for treating lung cancer and gastric cancer.
3. carboplatin
Carboplatin is a chemotherapy drug, which is mainly used to treat ovarian cancer, lung cancer, gastric cancer and other cancers. It inhibits the growth and spread of tumor cells by interfering with their DNA synthesis and repair. Carboplatin has become one of the most important drugs to treat various cancers because of its remarkable curative effect and wide indications.
Third, the market prospect of anticancer drugs in China
With people's increasing concern for health, the market of anticancer drugs is also expanding year by year. According to the data of market research institutions, the scale of China's anticancer drug market has reached 30 billion RMB in 20 19, and it is expected to maintain a high growth rate in the next few years. This trend provides a broad market space for the development and production of anticancer drugs.
In addition to the increase in market demand, policy support has also provided a strong guarantee for the development of China's anticancer drug market. In recent years, the China Municipal Government has successively issued a number of policies to support the development of the pharmaceutical industry, including increasing support for the research and development of anticancer drugs and increasing the proportion of medical insurance reimbursement. The introduction of these policies will further stimulate the innovation enthusiasm of pharmaceutical enterprises and promote the research and development and production of anticancer drugs.